CECLOR

This brand name is authorized in Australia, Austria, Brazil, Cyprus, Hong Kong SAR China, Malta, Mexico, Poland, Romania, Spain, Turkey.

Active ingredients

The drug CECLOR contains one active pharmaceutical ingredient (API):

1	Cefaclor monohydrate UNII 69K7K19H4L - CEFACLOR
	Cefaclor is a second-generation cephalosporin antibiotic. Cefaclor has no activity against Pseudomonas species or Acinetobacter species. Methicillin-resistant staphylococci and most strains of enterococci (eg, Str. faecalis) are resistant to cefaclor.
	Read more about Cefaclor

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CECLOR Granules	MPI, EU: SmPC	Medicines Authority (MT)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DC04	Cefaclor	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DC Second-generation cephalosporins
Discover more medicines within J01DC04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	1169M, 2460L, 2461M, 5045M, 5046N, 5047P
BR	Câmara de Regulação do Mercado de Medicamentos	531600706135410, 531600707131419, 531600803114317, 531600804110412
ES	Centro de información online de medicamentos de la AEMPS	55186, 59825
HK	Department of Health Drug Office	19285, 20110, 20158, 37919
MT	Medicines Authority	MA056/00601, MA056/00602, MA056/00603, MA056/00605
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	196M95
PL	Rejestru Produktów Leczniczych	100013235, 100013241, 100013258, 100013287, 100013293, 100081923, 100272617, 100276957
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64369001
TR	İlaç ve Tıbbi Cihaz Kurumu	8699638284474, 8699638284481